Entera Bio Ltd.

Entera Bio Ltd.verified

ENTX

Price:

$1.23

Market Cap:

$60.63M

Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that currently lack adequate treatments. Its primary experimental drugs are EB612, currently undergoing Phase II clinical assessment for hypoparathyroidism, and EB613, which has concluded Phase II studies for osteoporosis and is now in Phase I trials for treating non-healing bone fractures. Furthermore, the company holds a collaborative research and licensing pact with Amgen Inc. aimed at identifying and advancing potential therapeutic compounds for inflammatory conditions and other grave ailments. Estab...[Read more]

Industry

Biotechnology

IPO Date

2018-06-28

Stock Exchange

NASDAQ

Ticker

ENTX

The Enterprise Value as of June 2026 (TTM) for Entera Bio Ltd. (ENTX) is 56.94M

According to Entera Bio Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 56.94M. This represents a change of -22.19% compared to the average of 73.17M of the last 4 quarters.

Entera Bio Ltd. (ENTX) Historical Enterprise Value (quarterly & annually)

How has ENTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Entera Bio Ltd. over the last ten years is 37.95M. The current 56.94M Enterprise Value has changed 14.90% with respect to the historical average. Over the past ten years (40 quarters), ENTX's Enterprise Value was at its highest in in the June 2021 quarter at 121.25M. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

37.95M

Median

36.58M

Minimum

6.78M

Maximum

82.99M

Entera Bio Ltd. (ENTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Entera Bio Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 954.22%

Maximum Annual Enterprise Value = 82.99M

Minimum Annual Increase = -82.06%

Minimum Annual Enterprise Value = 6.78M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202582.99M16.19%
202471.43M954.22%
20236.78M-23.11%
20228.81M-82.06%
202149.11M318.67%
202011.73M5.95%
201911.07M-59.27%
201827.18M-40.89%
201745.99M-28.59%
201664.40M-21.04%

Entera Bio Ltd. (ENTX) Average Enterprise Value

How has ENTX Enterprise Value performed in the past?

The current Enterprise Value of Entera Bio Ltd. (ENTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

53.73M

5-year avg

43.82M

10-year avg

37.95M

Entera Bio Ltd. (ENTX) Enterprise Value vs. Peers

How is ENTX’s Enterprise Value compared to its peers?

Entera Bio Ltd.’s Enterprise Value is less than Anixa Biosciences, Inc. (82.74M), greater than VistaGen Therapeutics, Inc. (-27060355.00), less than Opus Genetics, Inc. (294.81M), less than Seer, Inc. (70.28M), less than TuHURA Biosciences, Inc. (141.90M), less than Acumen Pharmaceuticals, Inc. (105.89M), less than Seres Therapeutics, Inc. (105.86M), less than Spero Therapeutics, Inc. (111.36M), less than Agenus Inc. (406.89M), greater than Inovio Pharmaceuticals, Inc. (41.37M),

Build a custom stock screener for Entera Bio Ltd. (ENTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entera Bio Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Entera Bio Ltd. (ENTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Entera Bio Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Entera Bio Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Entera Bio Ltd. (ENTX)?

What is the 3-year average Enterprise Value for Entera Bio Ltd. (ENTX)?

What is the 5-year average Enterprise Value for Entera Bio Ltd. (ENTX)?

How does the current Enterprise Value for Entera Bio Ltd. (ENTX) compare to its historical average?